Yaxin Lu

1.2k total citations
48 papers, 712 citations indexed

About

Yaxin Lu is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Yaxin Lu has authored 48 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Oncology. Recurrent topics in Yaxin Lu's work include Connective tissue disorders research (4 papers), Analytical Chemistry and Chromatography (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). Yaxin Lu is often cited by papers focused on Connective tissue disorders research (4 papers), Analytical Chemistry and Chromatography (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). Yaxin Lu collaborates with scholars based in China, Australia and United Kingdom. Yaxin Lu's co-authors include Xiaonan Xi, Zheng Yin, Ning Liu, Qianqian Wang, Xing Tang, Yahui Ding, Yue Chen, Brett D. Hambly, Kangning Liu and Quan Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biophysical Journal.

In The Last Decade

Yaxin Lu

44 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaxin Lu China 16 273 140 77 71 70 48 712
Lijun Peng China 19 291 1.1× 77 0.6× 93 1.2× 25 0.4× 94 1.3× 63 901
Hong Huang China 18 306 1.1× 107 0.8× 54 0.7× 75 1.1× 92 1.3× 43 889
You Li China 12 250 0.9× 46 0.3× 64 0.8× 103 1.5× 34 0.5× 29 598
Pengke Yan China 15 240 0.9× 90 0.6× 48 0.6× 48 0.7× 47 0.7× 36 591
Guobing� Li China 23 805 2.9× 205 1.5× 67 0.9× 96 1.4× 58 0.8× 47 1.4k
Yunzhan Li China 13 273 1.0× 82 0.6× 68 0.9× 70 1.0× 29 0.4× 18 710
Xingchen Liu China 17 342 1.3× 83 0.6× 102 1.3× 74 1.0× 86 1.2× 67 838
Bin Song China 18 454 1.7× 215 1.5× 98 1.3× 24 0.3× 66 0.9× 60 844
Xiang Yang China 14 445 1.6× 63 0.5× 32 0.4× 79 1.1× 71 1.0× 23 807

Countries citing papers authored by Yaxin Lu

Since Specialization
Citations

This map shows the geographic impact of Yaxin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaxin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaxin Lu more than expected).

Fields of papers citing papers by Yaxin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaxin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaxin Lu. The network helps show where Yaxin Lu may publish in the future.

Co-authorship network of co-authors of Yaxin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yaxin Lu. A scholar is included among the top collaborators of Yaxin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaxin Lu. Yaxin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Can, Mengmeng Wang, Yan Jiao, et al.. (2025). BE-43547A2 exerts hypoxia-selective inhibition on human pancreatic cancer cells through targeting eEF1A1 and disrupting its association with FoxO1. Acta Pharmacologica Sinica. 46(5). 1433–1444. 1 indexed citations
3.
Liu, Wenhui, Yaxin Lu, Shuqi Li, et al.. (2025). A TME-responsive polysaccharide nanoplatform integrating synergetic therapy for cancer. International Journal of Biological Macromolecules. 327(Pt 1). 147113–147113.
4.
Ding, Xiaojing, et al.. (2024). Vitexicarpin suppresses malignant progression of colorectal cancer through affecting c-Myc ubiquitination by targeting IMPDH2. Phytomedicine. 132. 155833–155833. 2 indexed citations
5.
Xi, Xiaonan, Mingxiao Zhang, Xiang Zhang, et al.. (2024). Structure-Activity Relationship Study of Majusculamide D: Overcoming Metabolic Instability and Severe Toxicity with a Fluoro Analogue. Marine Drugs. 22(12). 537–537. 2 indexed citations
6.
7.
Lu, Yaxin, Jiamei Lu, Jie Zhang, et al.. (2024). Causal association between genetically predicted circulating immune cell counts and frailty: a two-sample Mendelian randomization study. Frontiers in Immunology. 15. 1336498–1336498. 1 indexed citations
8.
Xi, Xiaonan, et al.. (2023). Synthesis of Anti‐Pancreatic Cancer Natural Product Majusculamide D and Analogues Reveals a Preliminary Structure‐Activity Relationships. Chinese Journal of Chemistry. 42(6). 605–610. 3 indexed citations
9.
Lu, Yaxin, Shishi Shen, Ling Fang, et al.. (2023). Predictors for acute respiratory failure in AQP4-IgG-positive neuromyelitis optica spectrum disorders patients with medullary lesions. Journal of Clinical Neuroscience. 114. 131–136.
10.
Liu, Zifeng, Zhiqiang Nie, Yaxin Lu, et al.. (2022). Prevalence of multiple sclerosis in Guangzhou, China: A population-based case-finding prospective study. Multiple Sclerosis and Related Disorders. 68. 104151–104151. 1 indexed citations
11.
Huang, Zhen, et al.. (2022). The Mechanisms of Sodium Chloride Stress Mitigation by Salt-Tolerant Plant Growth Promoting Rhizobacteria in Wheat. Agronomy. 12(3). 543–543. 18 indexed citations
12.
Xi, Xiaonan, Ning Liu, Qianqian Wang, et al.. (2019). ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma. Cell Death and Disease. 10(10). 757–757. 101 indexed citations
13.
14.
Xi, Xiaonan, Qianqian Wang, Haibo He, et al.. (2018). Pharmacokinetics, tissue distribution and excretion of ACT001 in Sprague-Dawley rats and metabolism of ACT001. Journal of Chromatography B. 1104. 29–39. 30 indexed citations
15.
Guo, Wanjun, Linna Li, Chengwang Xu, et al.. (2015). Micheliolide Derivative DMAMCL Inhibits Glioma Cell Growth In Vitro and In Vivo. PLoS ONE. 10(2). e0116202–e0116202. 62 indexed citations
16.
Wang, Zhihong, Yaxin Lu, Kang Qin, et al.. (2015). Enzyme-functionalized vascular grafts catalyze in-situ release of nitric oxide from exogenous NO prodrug. Journal of Controlled Release. 210. 179–188. 81 indexed citations
17.
Wang, Wenjun, et al.. (2015). Quantitative performance of online SPE-LC coupled to Q-Exactive for the analysis of sofosbuvir in human plasma. RSC Advances. 5(119). 98269–98277. 21 indexed citations
18.
Lu, Yaxin, et al.. (2012). Marfan Syndrome Mutations Predominantly Alter Fibrillin Domain Folding. Biophysical Journal. 102(3). 251a–251a.
19.
Gao, Zhihui, Yu Tang, Jiaqi Chen, et al.. (2009). A novel DPP-IV-resistant analog of glucagon-like peptide-1 (GLP-1): KGLP-1 alone or in combination with long-acting PLGA microspheres. Peptides. 30(10). 1874–1881. 11 indexed citations
20.
Lu, Yaxin, et al.. (2007). Sucrose acetate isobutyrate as an In Situ forming system for sustained risperidone release. Journal of Pharmaceutical Sciences. 96(12). 3252–3262. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lijun Peng Breakdown of academic impact, for papers by Hong Huang Breakdown of academic impact, for papers by You Li Breakdown of academic impact, for papers by Pengke Yan Breakdown of academic impact, for papers by Guobing� Li Breakdown of academic impact, for papers by Yunzhan Li Breakdown of academic impact, for papers by Xingchen Liu Breakdown of academic impact, for papers by Bin Song Breakdown of academic impact, for papers by Xiang Yang
Rankless by CCL
2026